Articles tagged with Streptococcus
Exposure to a mild strain of Streptococcus pyogenes (Strep A) triggers the body's immune response and builds protection against future infections. This natural immunity mechanism may also apply to other common infections, offering new insights into prevention and treatment strategies.
Scientists have created a novel antibiotic that targets starved bacteria by blocking energy-coupling factor transporters. The breakthrough offers hope for tackling drug-resistant infections, with promising results in mouse models and no resistant bacterial variants emerging.
A recent study by University of Gothenburg researchers found that antibiotics for uncomplicated acute sore throats have minimal preventive effect against serious streptococcal infections. Early recognition of warning signs is crucial, and a vaccine is being awaited as a long-term solution.
Research reveals postpartum GBS strains with mutations that allow them to survive in the birth canal and resist treatment. Identifying these mutations is crucial for understanding how GBS is evading antibiotic treatment and finding new drug targets.
A new study reveals rising rates of invasive SDSE infections across Australia, particularly among older Australians and those from remote regions. The research highlights disparities in health outcomes between regions and populations, emphasizing the need for improved surveillance and prevention strategies.
Researchers discover epicatechin gallate, a compound from maple, can prevent biofilm formation of Streptococcus mutans, causing dental caries. The compound may be used in safer alternative mouthwashes for young children.
Japanese scientists have identified a novel genetic mutation in Streptococcus pyogenes associated with severe invasive infections. The mutation weakens bacterial growth in human blood and has been found unique to Japanese isolates, indicating a new pathogenic mechanism.
A recent study published in PLOS ONE found that higher maternal selenium levels during pregnancy are associated with a lower risk of streptococcal infections in children. The research tracked over 74,000 mothers and their children to explore potential links between maternal metal exposure and infection risk.
Invasive group A Streptococcus infections increased substantially in 10 US states between 2013 and 2022. Accelerated prevention efforts are needed, especially among high-risk groups, to combat the spread of this bacterial infection.
Researchers at Houston Methodist have identified a new strain of bacteria, Streptococcus dysgalactiae subspecies equisimilis (SDSE), linked to increasingly severe human infections. The study used integrative analysis to investigate the genome, transcriptome, and virulence of SDSE strains, shedding light on their molecular pathogenesis.
Researchers developed a nanomedicine that attacks bacteria at the molecular level, reducing antibiotic resistance and side effects. The technology releases medication only when required, ensuring patients take exact amounts to fight infections.
A new study has identified novel strains of microbes that have adapted to use limited resources in cities, including those found in Hong Kong's subways and skin. These microbes can metabolize manufactured products, posing health risks if they are pathogenic.
Researchers at Kobe University have discovered a new method to inhibit streptococcal infections by using aggregates of the non-toxic molecule Mn007. The study found that aggregates of Mn007 significantly reduce bacterial growth, suggesting potential as an effective treatment for toxic shock syndrome.
Researchers found that vaccination of neonatal mice with group A Streptococcus promotes clonal expansion of innate-like B cells producing antibody against N-acetyl-D-glucosamine (GlcNAc), reducing Type 1 diabetes risk. These GlcNAc-specific B-1 B cells aid in producing tolerance, facilitating efficient clearance of apoptotic beta cells...
Researchers discovered that women carrying Group B Streptococcus bacteria are up to three times more likely to have newborns admitted to neonatal units. The team developed an ultrasensitive PCR test to detect the bacteria, suggesting a 'cytokine storm' may be behind increased risk of disease.
Researchers found that genetic variants of the STING gene and bacterial NADase enzyme activity interact to determine disease severity. People with the risk variant of STING have a higher risk of life-threatening conditions, while those with the protective variant are less affected.
Researchers found a strong association between certain gut bacteria and coronary atherosclerotic plaques, which can lead to heart attacks. The study analyzed gut bacteria and cardiac imaging data from over 8,900 participants and identified Streptococcus species as key players.
Denmark has seen a significant surge in strep A infections, particularly among the elderly, since late 2022. The new M1 subvariant is responsible for 30% of cases and may be contributing to the outbreak's severity.
Infections caused by Group A Streptococcus (GAS) decreased by 80% as COVID-19 lockdown took effect and remained low until March 2022, when they increased 18% a month to surpass pre-COVID levels.
The highest incidence of invasive Group A Streptococcus (GAS) disease has shifted from the most deprived groups to the second most affluent group in the UK, according to new research. The emm1 strain, which causes severe disease, was more common in 2022 than previous years.
A study published by the University of Texas Health Science Center at Houston found a historic increase in group A strep infections among young children in Houston. The researchers identified three main types of group A strep diseases and found that emm12 strains were disproportionately represented, compared to emm1 strains.
Researchers discovered that fomepizole, an FDA-approved drug, can significantly reduce disease in mice infected with multidrug-resistant Streptococcus pneumoniae. The combination of fomepizole and erythromycin reduced bacterial burdens by 95% in the lungs and up to 700-fold in other organs.
A global maternal Strep B vaccination program could avert over 200,000 cases and more than 31,000 deaths, as well as reduce disability in children. The study found that a one-dose vaccine program could cost $1.7 billion globally, while saving $385 million in healthcare costs.
A University of Queensland-led team has secured almost $8 million in philanthropic funding to develop an mRNA vaccine against Group A Streptococcus (Strep A), which causes over 500,000 deaths annually due to rheumatic heart disease.
Researchers at Lund University discovered an antibody with potential to protect against Strep A infection and a rare form of binding that leads to effective immune response. The finding could explain why many Group A strep vaccines have failed.
A new study found that the detection of resistant variants is only possible using population deep sequencing, suggesting treatment with antibiotics may contribute to their presence. The research highlights the potential for PDS to improve understanding of pathogens like Streptococcus pneumoniae and inform treatment strategies.
A global consortium has launched best practice surveillance protocols for Group A Streptococcus (Strep A) research, providing clear case definitions and guiding researchers in clinical trials. The new protocols aim to accelerate the development of a safe and effective Strep A vaccine.
Researchers discovered a novel role for an E. coli enzyme in reducing the toxic effects of hypothiocyanite, a key antimicrobial released by the human immune system. This finding has implications for diseases like cystic fibrosis and inflammatory bowel disease, as it suggests that various bacteria can evade this powerful oxidant.
Researchers investigate the role of gut bacteria in pneumonia infection in the elderly, finding that a leaky gut can lead to inflamed lungs. The study suggests that aging compromises immune system control over bacteria, allowing them to migrate to other parts of the body and cause poor outcomes.
A new study published in Neurology found that exposure to strep throat does not increase the risk of developing tics in children who have a parent or sibling with a chronic tic disorder. Researchers followed 259 children for an average of 1.6 years and found no association between strep infection and tic development.
Researchers confirm that skin infections, not just throat infections, trigger acute rheumatic fever, with Māori and Pacific children at highest risk. The study's findings have huge implications for prevention, suggesting a new focus on addressing skin infections to reduce the risk of rheumatic fever in New Zealand and internationally.
A new report highlights the alarming global impact of Group B streptococcus, which can lead to up to 150,000 infant deaths annually. Maternal vaccination is seen as a cost-effective solution to reduce this toll, with significant health benefits in all regions.
A recent study published in Annals of the Rheumatic Diseases reveals a link between systemic lupus erythematosus and an altered gut microbiome. Researchers at Osaka University identified two species of Streptococcus bacteria significantly increased in SLE patients, which can affect the body's functions by altering plasma metabolites. T...
Researchers discovered that human milk oligosaccharides can prevent GBS infections in cells and tissues, and in mouse models. The sugars may act as anti-adhesives and prebiotics to support good bacteria growth, making them a potential substitute for antibiotics.
Researchers characterize a new bacterial species causing severe respiratory disease in peccaries, contributing to better understanding of rare pathogens. The discovery uses MALDI-TOF mass spectrometry for rapid and reliable identification.
Research reveals dietary zinc intake protects against Streptococcus pneumoniae, a primary cause of pneumonia. Zinc deficiency increases susceptibility to bacterial infections.
A research team led by Natalia Korotkova has identified a potential target for developing a vaccine against Group A Streptococcus, which causes strep throat and other serious infections. The gacH gene, which enables the bacteria to reinforce its resistance to the immune system, is a promising candidate for vaccine design.
Scientists used a genetic tool to identify 72 key genes in group A strep that contribute to necrotizing myositis, a devastating human infection with high mortality rates. The study provides a genetic roadmap for developing new vaccines and treatments.
Researchers identify a novel connection between highly variant types of Streptococcus mutans and rampant caries in high-risk children. High-risk children carry more virulent variants of the bacteria with unique adhesive proteins that improve survival in the mouth.
A new report in The American Journal of Pathology reveals that potent cytotoxins produced by group A streptococcus (GAS) contribute to the severity of 'flesh-eating disease'. Production of both NADase and streptolysin O is necessary for full virulence, and infections can be controlled better with toxin-deficient bacteria.
Researchers found that smaller liposomes elicited higher levels of IgG and IgA antibodies in mice, while larger liposomes produced lower antibody titers. The study suggests that a mix of different liposome sizes can achieve similar results as the smallest liposomes.
Research provides new insights into Group A Streptococcus by demonstrating its toxin, Streptolysin S, targets a specific protein on red blood cells, leading to hemolysis. Chemical inhibition of this protein reduces the toxin's activity and alters the pathology of GAS in skin infections.
Researchers found that group B streptococcus mutations can promote virulence in infants, particularly after the first few days of life. The study identified specific genomic changes associated with increased virulence, highlighting the need for better therapeutic interventions against neonatal GBS infections.
Researchers found genetic changes in group A streptococcus that increase toxin production, contributing to large epidemics. The study provides new insights into the molecular basis of epidemic bacterial infections and potential strategies for developing novel therapeutics.
Scientists have discovered a new variant of Group A streptococcus that produces more toxin and has lost its outer capsule, leading to increased severity of infections. The new variant is spreading globally, with reports from Japan, Canada, France, and Sweden, raising concerns about periodic upsurges in disease cases.
A study by University of Liverpool researchers reveals that pneumolysin released during Streptococcus pneumoniae infection causes cardiac injury and death. Liposome therapy has been shown to neutralize the toxin, mitigating damage to heart muscle cells.
The incidence of early-onset and late-onset group B streptococcal disease increased in the Netherlands after guidelines were introduced, mainly due to a rise in virulent clonal complex 17 strains. Universal screening and antibiotic prophylaxis for pregnant women may be necessary to prevent all infections.
Researchers discovered how Group A streptococcus turns deadly and found a potential new treatment using asparaginase, a protein that digests asparagine. This study opens the way to possible new treatments for bacterial infections.
A global study reveals that antibiotic prophylaxis significantly reduces group B streptococcal infections in newborns, especially in Africa. The study's findings suggest developing vaccines could have near-universal applicability due to similar strain distributions worldwide.
Researchers have identified genetic similarities between Streptococcus pyogenes and Streptococcus equi, two bacteria that cause potentially fatal infections in humans and horses. The study suggests a shared strategy for causing disease and offers hope for developing novel vaccines for both species.
Researchers at The Forsyth Institute have identified a new pathogen, Scardovia wiggsiae, connected to severe early childhood caries. This bacterium was present in the mouths of children with severe ECC when other known pathogens like Streptococcus mutans were not detected.
Research study reveals that only a limited number of Streptococcus pneumoniae serotypes are responsible for most invasive pneumococcal disease globally. The top seven serotypes (1, 5, 6A, 6B, 14, 19F, and 23F) accounted for the majority of cases in every region worldwide.
The National Institutes of Health has awarded Eastman Dental Center's Hyun Koo $1.6 million to continue his work on preventing dental caries by disrupting bacterial biofilm formation. Koo's team has discovered compounds in cranberry and red wine grapes that may reduce the ability of bacteria to form plaque and cause cavities.
The incidence of group B streptococcus has decreased among infants younger than 7 days, but increased among adults aged 15-64 years and those over 65, according to a recent study. Disease trends following the release of guidelines for prevention near birth have not yet been well studied.
Researchers have uncovered how Streptococcus pneumoniae builds its penicillin immunity and opened up ways to disrupt this mechanism, potentially restoring penicillin as a weapon against the bacterium. The discovery also offers hope for treating MRSA using penicillin.
A £285,000 grant from The Wellcome Trust will support the development of new infection-control methods that do not rely on conventional antibiotics. The team will focus on understanding how Streptococcus bacteria interact with host tissues and proteins to identify targets for prevention.
The efficacy of AVELOX in treating complicated intra-abdominal infections was highlighted at ICAAC. The study showed that once-daily AVELOX monotherapy was as effective as combination therapy, with overall clinical cure rates of 80.9% and comparable duration of therapy.
A team of researchers led by Emanuel Hanski discovered a protein called SilCR that blocks the immune system's distress calls, making Group A Streptococcus bacteria more virulent. The findings could lead to new strategies for treating necrotizing fasciitis and halting its rapid destruction of tissue.
A recent study published in Annals of Surgery found AVELOX to be equally effective as a multi-dose combination therapy for treating intra-abdominal infections, with improved cure rates among hospital-acquired infections. The treatment showed a significantly higher cure rate and better safety profile compared to the standard regimen.
Researchers have developed a 3D modeling technique that shows how antibodies bind to bacterial sugars, allowing for potential new vaccines. This technique can be used to create new vaccines that protect against multiple strains of bacteria.